Cevimeline Hydrochloride is being studied as a treatment for dry mouth caused by radiation therapy to the head and neck. It is a parasympathomimetic and muscarinic agonist, with particular effect on M1 and M3 receptors. Reference standards of Cevimeline Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
3-Quinuclidinone Hydrochloride
Catalogue No.:PA 30 0371000
CAS :
Molecular Formula : C7H12ClNO
Molecular Weight : 161.63
Cevimeline Hydrochloride
Catalogue No.:PA 30 37000
Molecular Formula : C10H18ClNOS
Molecular Weight : 235.77
Cevimeline N-Oxide
Catalogue No.:PA 30 37510
Molecular Formula : C10H17NO2S
Molecular Weight : 215.31
(1S,3R,4S)-3-((Tritylthio)methyl)quinuclidin-3-ol
Catalogue No.:PA 30 37520
Molecular Formula : C27H29NOS
Molecular Weight : 415.59
(1'S,2S,3'R,4'S)-2-Methyl-1'-azaspiro[[1,3]oxathiolane-5,3'-bicyclo[2.2.2]octan]-1'-ium Chloride
Catalogue No.:PA 30 37530
3-Hydroxy-1-azabicyclo[2.2.2]octane-3-methanol
Catalogue No.:PA 30 37540
Molecular Formula : C8H15NO2
Molecular Weight : 157.21
Cevimeline Sulfoxide
Catalogue No.:PA 30 37550
trans-Cevimeline Hydrochloride
Catalogue No.:PA 30 37560
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
